High cost drugs - Vedolizumab
- Coding system
- No coding system
- Coding system release
- unknown
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/high-cost-drugs-vedolizumab
- Version ID
- 7f1d1179
Versions
- 7f1d1179
Description
This is a list of all the unique values from the Drug Name variable in the High Cost Drugs Dataset that relate to the prescribing of vedolizumab.
Methodology
The values in this variable do not follow a coding system so the selection for this codelist is based on the drug name value, after converting all text to lower case, containing one or more of the following strings (these are the generic medicine name and brand names):
- vedolizumab
- entyvio
All drug name values that contain at least one of the above strings are included in the vedolizumab group and assigned the VTM (virtual therapeutic moiety) code 704257002.
References
Signed off by
- Mark Yates, (Feb. 26, 2021)
- Nick Kennedy, (Feb. 26, 2021)
- Anna Rowan, (Feb. 26, 2021)
- Sinéad langan, (Feb. 26, 2021)
- James Galloway, (Feb. 26, 2021)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| olddrugname |
|---|
| cyto vedolizumab in sodium chloride 0.9% infusion |
| entyvio 300mg powder for concentrate for solution for infusion vials (takeda uk ltd) |
| entyvio 300mg powder for concentrate for solution for infusion vials (takeda uk ltd) 1 vial |
| entyvio300mgpowderforconcentrateforsolutionforinfusionvials(takedaukltd)1vial |
| vedolizumab |
| vedolizumab 300mg intravenous infusion civas |
| vedolizumab 300mg intravenous infusion civas aseptic fee |
| vedolizumab 300mg intravenous infusion civas aseptic fee |
| vedolizumab 300mg intravenous infusion civas ase |
| vedolizumab 300mg intravenous infusion civas aseptic fee |
| vedolizumab 300mg powder for concentrate for solution for infusion |
| vedolizumab infusion 1 bag pack |
| vedolizumab $ |
| vedolizumab (bi) |
| vedolizumab (bi) 300 mg in sodium chloride 0.9% intravenous infusion 1 bag dose |
| vedolizumab (bi) 300 mg in sodium chloride 0.9% intravenous infusion 1 bag stock dose |
| vedolizumab (entyrio) |
| vedolizumab (entyvio) |
| vedolizumab (entyvio) 300 mg injection |
| vedolizumab (entyvio) 300 mg intravenous infusion |
| vedolizumab (entyvio) 300mg/25 |
| vedolizumab (entyvio) 300mg/250ml (250 ml pack) |
| vedolizumab 300 mg injection |
| vedolizumab 300 mg injection powder |
| vedolizumab 300 mg intravenous infusion |
| vedolizumab 300 mg powder for infusion |
| vedolizumab 300 mg powder for soln for infusion |
| vedolizumab 300 mg powder for soln for injection |
| vedolizumab 300 mg pwd for soln for infusion vial |
| vedolizumab 300 mg/255 ml |
| vedolizumab 300mg |
| vedolizumab 300mg sodium chloride 0.9% 250ml asu |
| vedolizumab 300mg in 255ml sodium chloride 0.9% |
| vedolizumab 300mg in sod chloride 0.9% 250ml(qua1) |
| vedolizumab 300mg in sodium chloride 0.9% 250ml |
| vedolizumab 300mg in sodium chloride 0.9% 250ml (baxt1) |
| vedolizumab 300mg in sodium chloride 0.9% 250ml asu |
| vedolizumab 300mg in sodium chloride 0.9% inf 250ml |
| vedolizumab 300mg in sodium chloride 0.9%250ml asu |
| vedolizumab 300mg in sodium chloride0.9% 250ml asu |
| vedolizumab 300mg in!sod chloride 0.9% 250ml(qua1) |
| vedolizumab 300mg in!sodium chloride 0.9% 250ml |
| vedolizumab 300mg infusion |
| vedolizumab 300mg powder |
| vedolizumab 300mg powder for conc for inf (entyvio |
| vedolizumab 300mg powder for concentrate for infus |
| vedolizumab 300mg powder for concentrate for infusion(1) |
| vedolizumab 300mg powder for solution for infusion |
| vedolizumab 300mg powder for solution for infusion vials |
| vedolizumab 300mg powder for solution for infusion vials 1 vial |
| vedolizumab 300mg powder!for concentrate!for infusion |
| vedolizumab 300mg sodium chloride 0.9% 250ml asu |
| vedolizumab 300mg sodium chloride 0.9% infusion (1 |
| vedolizumab 300mg vial |
| vedolizumab 300mg/250ml sodium chloride 0.9% infus |
| vedolizumab in sodium chloride (bath asu - qualasept) |
| vedolizumab in sodium chloride (bath asu - qualasept) 300 mg infusion |
| vedolizumab in sodium chloride 0.9% |
| vedolizumab in sodium chloride 0.9% (whiston) |
| vedolizumab in sodium chloride 0.9% (whiston) 300 mg infusion |
| vedolizumab in sodium chloride 0.9% 300 mg infusion |
| vedolizumab iv infusion multiple patient civas |
| vedolizumab iv infusion single patient civas |
| vedolizumab powder for soln for infusion 300mg |
| vedolizumab!300mg!infusion (cpd) |
| vedolizumab!300mg!powder for concentrate for infus |
| vedolizumab!300mg!powder for concentrate for infusion(1) |
| vedolizumab!300mg!powder for concentrate!for infusion(1) |
| vedolizumab^ (final product) |
| vedolizumab^ (final product) 300 mg bag |